Increased expression of chitinase 3-like 1 in aorta of patients with atherosclerosis and suppression of atherosclerosis in apolipoprotein e-knockout mice by chitinase 3-like 1 gene silencing

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Gong, Zushun ^a   Xing, Shanshan ^b   Zheng, Fei ^a   Xing, Qichong ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHITINASE; CHITINASE 3 LIKE 1; COLLAGEN; GELATINASE B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 8; LENTIVIRUS VECTOR; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN KINASE B; SMALL INTERFERING RNA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ADIPOCYTOKINE; CHI3L1 PROTEIN, HUMAN; CHITINASE 3-LIKE 1, MOUSE; GLYCOPROTEIN; LECTIN; MESSENGER RNA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; ENZYME INHIBITION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY DONOR; LIPOPROTEIN BLOOD LEVEL; MACROPHAGE; MALE; MIDDLE AGED; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; SMOOTH MUSCLE FIBER; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; ATHEROSCLEROSIS; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; INFLAMMATION; KNOCKOUT MOUSE; LENTIVIRINAE; METABOLISM; RISK FACTOR;

ADIPOKINES; ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; COLLAGEN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE SILENCING; GLYCOPROTEINS; HEK293 CELLS; HUMANS; INFLAMMATION; LECTINS; LENTIVIRUS; MALE; MICE; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; RISK FACTORS; RNA INTERFERENCE; RNA, MESSENGER;

EID: 84896903778     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/905463     Document Type: Article

References (27)

1. Ross R., Atherosclerosis-an inflammatory disease. The New England Journal of Medicine 1999 340 2 115 126 2-s2.0-0033552883 10.1056/NEJM199901143400207 (Pubitemid 29054847)
2. Nakashima Y., Raines E. W., Plump A. S., Breslow J. L., Ross R., Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the apoE-deficient mouse. Arteriosclerosis, Thrombosis, and Vascular Biology 1998 18 5 842 851 2-s2.0-0031806684 (Pubitemid 28267666)
3. Rathcke C. N., Vestergaard H., YKL-40-an emerging biomarker in cardiovascular disease and diabetes. Cardiovascular Diabetology 2009 8, article 61 2-s2.0-71949101822 10.1186/1475-2840-8-61
4. Lee C. G., Da Silva C. A., Dela Cruz C. S., Ahangari F., Ma B., Kang M.-J., He C.-H., Takyar S., Elias J. A., Role of chitin and chitinase/chitinase- like proteins in inflammation, tissue remodeling, and injury. Annual Review of Physiology 2011 73 479 501 2-s2.0-79951776429 10.1146/annurev-physiol-012110- 142250
5. Chupp G. L., Lee C. G., Jarjour N., Shim Y. M., Holm C. T., He S., Dziura J. D., Reed J., Coyle A. J., Kiener P., Cullen M., Grandsaigne M., Dombret M.-C., Aubier M., Pretolani M., Elias J. A., A chitinase-like protein in the lung and circulation of patients with severe asthma. The New England Journal of Medicine 2007 357 20 2016 2027 2-s2.0-36148981436 10.1056/NEJMoa073600 (Pubitemid 350106709)
6. Ma W. H., Wang X. L., Du Y. M., Association between human cartilage glycoprotein 39 (YKL-40) and arterial stiffness in essential hypertension. BMC Cardiovascular Disorders 2012 12 35 10.1186/1471-2261-12-35
7. Rathcke C. N., Persson F., Tarnow L., Rossing P., Vestergaard H., YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria. Diabetes Care 2009 32 2 323 328 2-s2.0-61849086267 10.2337/dc08-1144
8. Røndbjerg A. K., Omerovic E., Vestergaard H., YKL-40 levels are independently associated with albuminuria in type 2 diabetes. Cardiovascular Diabetology 2011 10, article 54 2-s2.0-79959370232 10.1186/1475-2840-10-54
9. Kyrgios I., Galli-Tsinopoulou A., Stylianou C., Papakonstantinou E., Arvanitidou M., Haidich A.-B., Elevated circulating levels of the serum acute-phase protein YKL-40 (chitinase 3-like protein 1) are a marker of obesity and insulin resistance in prepubertal children. Metabolism 2012 61 4 562 568 2-s2.0-84858446769 10.1016/j.metabol.2011.09.004
10. Kucur M., Isman F. K., Karadag B., Vural V. A., Tavsanoglu S., Serum YKL-40 levels in patients with coronary artery disease. Coronary Artery Disease 2007 18 5 391 396 2-s2.0-34547531506 10.1097/MCA.0b013e328241d991 (Pubitemid 47186840)
11. Michelsen A. E., Rathcke C. N., Skjelland M., Holm S., Ranheim T., Krohg-Sørensen K., Klingvall M. F., Brosstad F., Øie E., Vestergaard H., Aukrust P., Halvorsen B., Increased YKL-40 expression in patients with carotid atherosclerosis. Atherosclerosis 2010 211 2 589 595 2-s2.0-77955275761 10.1016/j.atherosclerosis.2010.02.035
12. Batinic K., Höbaus C., Grujicic M., Steffan A., Jelic F., Lorant D., Hörtenhuber T., Hoellerl F., Brix J.-M., Schernthaner G., Koppensteiner R., Schernthaner G.-H., YKL-40 is elevated in patients with peripheral arterial disease and diabetes or pre-diabetes. Atherosclerosis 2012 222 2 557 563 2-s2.0-84860594336 10.1016/j.atherosclerosis.2012.03.034
13. Mathiasen A. B., Harutyunyan M. J., Jrgensen E., Helqvist S., Ripa R., Gtze J. P., Johansen J. S., Kastrup J., Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease. Scandinavian Journal of Clinical and Laboratory Investigation 2011 71 5 439 447 2-s2.0-80051762448 10.3109/00365513.2011.586470
14. von der Thüsen J. H., van Berkel T. J. C., Biessen E. A. L., Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice. Circulation 2001 103 8 1164 1170 2-s2.0-0035957021 (Pubitemid 32200193)
15. -/- mice after adenovirus-mediated transfer of p53. Circulation 2002 105 17 2064 2070 2-s2.0-0037197723 10.1161/01.CIR.0000015502.97828.93 (Pubitemid 34465269)
16. Burger-Kentischer A., Göbel H., Kleemann R., Zernecke A., Bucala R., Leng L., Finkelmeier D., Geiger G., Schaefer H. E., Schober A., Weber C., Brunner H., Rütten H., Ihling C., Bernhagen J., Reduction of the aortic inflammatory response in spontaneous atherosclerosis by blockade of macrophage migration inhibitory factor (MIF). Atherosclerosis 2006 184 1 28 38 2-s2.0-28344441098 10.1016/j.atherosclerosis.2005.03.028 (Pubitemid 41721066)
17. Zhang W., Kawanishi M., Miyake K., Kagawa M., Kawai N., Murao K., Nishiyama A., Fei Z., Zhang X., Tamiya T., Association between YKL-40 and adult primary astrocytoma. Cancer 2010 116 11 2688 2697 2-s2.0-77952854217 10.1002/cncr.25084
18. Faibish M., Francescone R., Bentley B., Yan W., Shao R., A YKL-40-neutralizing antibody blocks tumor angiogenesis and progression: a potential therapeutic agent in cancers. Molecular Cancer Therapeutics 2011 10 5 742 751 2-s2.0-79956057857 10.1158/1535-7163.MCT-10-0868
19. Rathcke C. N., Vestergaard H., YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflammation Research 2006 55 6 221 227 2-s2.0-33748485114 10.1007/s00011-006-0076-y (Pubitemid 44359135)
20. Boot R. G., Van Achterberg T. A. E., Van Aken B. E., Renkema G. H., Jacobs M. J. H. M., Aerts J. M. F. G., De Vries C. J. M., Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 3 687 694 2-s2.0-0032975495 (Pubitemid 29135172)
21. Matta H., Hozayev B., Tomar R., Chugh P., Chaudhary P. M., Use of lentiviral vectors for delivery of small interfering RNA. Cancer Biology and Therapy 2003 2 2 206 210 2-s2.0-0141872579 10.4161/cbt.2.2.348
22. Morris K. V., Rossi J. J., Lentiviral-mediated delivery of siRNAs for antiviral therapy. Gene Therapy 2006 13 6 553 558 2-s2.0-33645144814 10.1038/sj.gt.3302688
23. Kawada M., Seno H., Kanda K., Nakanishi Y., Akitake R., Komekado H., Kawada K., Sakai Y., Mizoguchi E., Chiba T., Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer. Oncogene 2011 2-s2.0-80155163949 10.1038/onc.2011.498
24. Chen C.-C., Llado V., Eurich K., Tran H. T., Mizoguchi E., Carbohydrate-binding motif in chitinase 3-like 1 (CHI3L1/YKL-40) specifically activates Akt signaling pathway in colonic epithelial cells. Clinical Immunology 2011 140 3 268 275 2-s2.0-80051786619 10.1016/j.clim.2011.04.007
25. Ozeren A., Aydin M., Tokac M., Demircan N., Unalacak M., Gurel A., Yazici M., Levels of serum IL-1 β IL-2, IL-8 and tumor necrosis factor- in patients with unstable angina pectoris. Mediators of Inflammation 2003 12 6 361 365 2-s2.0-0742321794 10.1080/09629350310001633360 (Pubitemid 38161144)
26. Kong Y.-Z., Yu X., Tang J.-J., Ouyang X., Huang X.-R., Fingerle-Rowson G., Bacher M., Scher L. A., Bucala R., Lan H. Y., Macrophage migration inhibitory factor induces MMP-9 expression: implications for destabilization of human atherosclerotic plaques. Atherosclerosis 2005 178 1 207 215 2-s2.0-10044226344 10.1016/j.atherosclerosis.2004.08.030 (Pubitemid 39600835)
27. Moehle C. W., Bhamidipati C. M., Alexander M. R., Mehta G. S., Irvine J. N., Salmon M., Upchurch G. R. Jr., Kron I. L., Owens G. K., Ailawadi G., Bone marrow-derived MCP1 required for experimental aortic aneurysm formation and smooth muscle phenotypic modulation. Journal of Thoracic and Cardiovascular Surgery 2011 142 6 1567 1574 2-s2.0-81255137066 10.1016/j.jtcvs.2011.07.053